https://www.selleckchem.com/
The purpose of this study was to investigate the attainment of treatment goals according to the European Consensus Programme (ECP-TGs) from 2011 in patients with moderate to severe psoriasis (Pso) treated with the first conventional systemic therapy and to identify factors that might compromise the attainment of these treatment goals. In a multicenter, prospective observational study, patients with moderate to severe Pso, defined as either body surface area (BSA) 10% or psoriasis area severity index (PASI) 10 and dermatology life quality index (DLQI
Like
Comment
Share
